| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |